Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, ...

Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical company advancing a pipeline of therapeutic candidates addressing hard-to-treat tumors and viruses. The Company's lead program ...

Helm Undergraduate Research Day on Wednesday, April 16, in the University Union. This is a public, university-wide forum for showcasing undergraduate research from all academic disciplines, and ...

The full abstract will be published online on April 25, 2025. More details about the programs for the AACR Annual Meeting 2025 are available online at AACR Annual Meeting 2025 | Meetings | AACR.

Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001Erasca will also present ...

C.A. Details of the poster presentation are as follows: Abstract Title: ADI-270, an Armored Allogeneic Anti-CD70 γδ CAR T Cell Therapy, Demonstrates Improved Efficacy and Safety in Preclinical ...

Presenting a poster at the 2025 ICUR is an opportunity to share your work with the community, get feedback on your research, network with fellow researchers and build communication skills. Abstract ...

A Toronto artist is sharing his detailed process behind the making of his hard-to-miss FIFA World Cup 2026 host city poster.

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH studies in 2025 for the treatment of small cell lung cancer Firs ...

Sahaj, who works for a Delhi-based firm from Rajkot as an AI Policy Researcher, will also make a presentation from the United Nations dias for international dignitaries and delegates from all over the ...